Loading clinical trials...

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 4NCT01368536

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

This was a study to assess the safety and efficacy of Valturna and amlodipine or Valturna and chlorthalidone when compared to Valturna alone in patients with stage 2 hypertension and diabetes mellitus...

Lead sponsor: Novartis Pharmaceuticals•95 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

RECRUITINGNA

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

RECRUITINGNA

Fiber mHealth Intervention for Prediabetes

NCT07491653 · Prediabetes

RECRUITINGNA

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

NCT05912647 · Diabetes, Diabetes Type 2

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 21, 2013Terms

Trial snapshot

StatusTERMINATED

PhasePHASE4

Enrollment975

Start dateMay 2011

Last updatedMar 21, 2013

Condition

Hypertension Stage 2 Hypertension Diabetes

Locations shown

Novartis Investigative Site

Athens, Alabama

Novartis Investigative Site

Florence, Alabama

Novartis Investigative Site

Huntsville, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 21, 2013Data synced to Clareo: June 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

Treatment With Aspirin After Preeclampsia: TAP Trial

Fiber mHealth Intervention for Prediabetes

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

Trial snapshot

Condition

Locations shown

For caregivers